SR-31747 free base has been studied for its potential applications in the field of immunology and oncology. It is known to interact with sigma receptors, which are implicated in various cellular processes, including modulation of immune responses and cancer cell proliferation. Research suggests that SR-31747 may exhibit anti-tumor properties by inducing apoptosis in certain cancer cells and inhibiting their growth. Additionally, it has been explored for its immunomodulatory effects, potentially enhancing the body's immune response against infections or malignancies. Its ability to bind to sigma receptors also makes it a candidate for further investigation in neurological disorders, where these receptors play a role. However, its clinical applications remain under study, and further research is needed to fully understand its therapeutic potential and safety profile.